Health Care Reform

A provision in Congress's opioid bill expands the FDA's power to “debar” people “from importing or offering for import" drugs under certain circumstances.

Azar called the proposal a "misnomer" that "won't resemble Medicare at all.”

The divestiture of Aetna's Medicare Part D plans to WellCare may help resolve objections from U.S. antitrust regulators.

Both parties expect record-breaking fundraising for this year's 30 contested elections for state attorneys general.

Contract negotiations between have hit a snag because Envision “demands to be paid much more than Medicare pays for the same services."

As the opioid epidemic continues to rage across the country, the fallout is increasingly manifesting itself in the workplace.